WVU Hospitals and School of Pharmacy Residency Program

PGY-2 PROGRAMS

Number of Positions:
PGY-2 Critical Care – 1
PGY-2 Infectious Diseases – 1
PGY-2 Internal Medicine – 1
PGY-2 Oncology – 1

Starting Date: All Residents – July 5, 2017
Estimated Stipend: $46,000+
Interview Required: Yes

Fringe Benefits: Comprehensive flexible benefits packages including medical, dental, vision, life and disability. In addition, the residents receive paid days off, paid holidays, and financial support for travel to professional and educational programs and professional society meetings.


Internal Medicine (PGY2)
ASHP Accredited
Director: Jay Martello, Pharm.D., BCPS

The PGY-2 Internal Medicine Residency Program is designed to provide the opportunity for the resident to obtain advanced training in the area of internal medicine and its sub-specialties. The resident will receive well-rounded training experience that will enable the resident to succeed in the areas of service, teaching, and scholarly activities. Service experiences include clinical service, formulary management, medication-use evaluation, and distribution. The internal medicine services are academic teaching services run by physicians who value pharmacy services and are receptive to pharmacy contributions to teaching and patient care. Teaching experiences include didactic teaching, small group facilitation, experiential precepting, and human-patient simulation. Scholarly experiences include preparation of a manuscript for publication, presentation of a professional poster at a national meeting, and development of a longitudinal research project. Required rotations include Internal Medicine (x3), MICU (x1), a longitudinal outpatient Family Medicine Clinic, and 4 open elective experiences. Rotations are structured to meet personal interests. In addition, an optional international rotation in South Africa is also available as an unique learning experience. The program’s goal is to prepare the resident for a position in any number of areas of internal medicine practice, including academia and clinical specialist positions.

Infectious Disease (PGY2)
ASHP Accredited
Director: Doug Slain, Pharm.D., BCPS

The PGY-2 Infectious Disease Residency Program is an organized, directed postgraduate training program that centers on developing the competencies necessary to provide pharmacist care to patients with infectious diseases. The resident will receive well-rounded training experience that will enable the resident to succeed in the areas of service, teaching, and scholarly activities. Most of the resident’s clinical experiences will be on the infectious diseases consult team. The resident will also complete experiences or rotations in clinical microbiology laboratory, antimicrobial stewardship, critical care unit, HIV Clinic, and on the bone marrow transplant service. Additional elective experiences can be scheduled to meet the resident’s interests. The resident will actively participate on the Antimicrobial Stewardship Subcommittee of the Pharmacy and Therapeutics Committee and will gain experience in formulary development and evidence-based decision making.

Critical Care (PGY2)
ASHP Accredited
Director: Rich McKnight, Pharm.D.

The PGY-2 Critical Care Residency Program is organized and designed to provide the postgraduate resident the opportunity for advanced training in the critical care arena. The resident will complete multiple learning experiences in the Medical Intensive Care Unit as well as the Surgical Intensive Care Unit. Additionally, the Critical Care Resident may complete rotations in Trauma, Pediatric Intensive Care, Emergency Medicine, Bone Marrow Transplant, and Infectious Diseases. Upon completion, the resident will have the ability to practice within all facets of critical care. The resident also will actively participate on the Pharmacy and Therapeutics committee as well as the Formulary Subcommittee. The resident will be expected to teach within the intensive care units as well as at the West Virginia University School of Pharmacy.

Oncology (PGY2)
ASHP Accredited
Director: Aaron Cumpston, Pharm.D., BCOP

The PGY-2 Oncology Residency Program is designed to develop the specialized knowledge, competency and skill necessary to provide pharmacist care to patients with cancer. The resident will be actively involved in managing the therapeutic decisions and clinical outcomes of cancer patients in an interdisciplinary environment. The resident will participate in all aspects of oncology pharmacy practice pertaining to clinical practice and outcomes, research, and education. Required practice experiences include medical oncology, malignant hematology / stem cell transplant, pediatric oncology, ambulatory oncology clinic, and palliative care. The resident will also gain experience in clinical pharmacology research, as well as development of their teaching skills. The program’s goal is to prepare the resident for a clinical position in an established cancer center or to be able to design and implement an oncology pharmacy service in another practice setting.